The quality of care patients received - that is according to where they have the procedure - accounts for the variation in the rate of complications after having implants such as the cardiovascular implantable electronic device(CIED). The devices are usually permanent pacemakers or implantable cardioverter-defibrillators.
The chances of patients experiencing complications after having a cardiac device implanted vary according to where they have the procedure.
Doctors are in Favor of Traditional Cardiac Surgery Despite Better Alternative
The chances of a re-surgery significantly comes down to less than 3% cases and less than 5% cases in 10 and 20 years time respectively if the surgeon opts for BIMA grafting.
Advertisement
‘There is a need to reduce cardiac e-device implantation complications over time by auditing complications and engaging in clinical quality registries.’
Read More..
Tweet it Now
Read More..
A study of 174 hospitals in Australia and New Zealand published today in the Annals of Internal Medicine shows that the quality of care people receive may account for the wide variation in the rate of complications after having a cardiovascular implantable electronic device (CIED) insertion.
"The study included 81,304 patients who received a new CIED with 65,711 permanent pacemakers and 15,593 implantable cardioverter-defibrillators," says the study's lead author, University of Adelaide's Dr Isuru Ranasinghe, Senior Cardiologist, Central Adelaide Local Health Network.
![Restrictive Transfusion Therapy Benefits Cardiac Surgery Patients]( "Restrictive Transfusion Therapy Benefits Cardiac Surgery Patients")
Lower thresholds for blood transfusions for cardiac surgery patients compared to traditional thresholds provide positive patient outcomes and safety at six months after surgery.
"Permanent pacemakers and implantable cardioverter-defibrillators are among the most common and costly devices implanted in hospitals."
"CIED complications are common with 8.2 per cent of patients implanted with new devices having a major device-related complication within 90 days of their operation. Complications experienced by patients vary between 2- and 3-fold among hospitals, which suggests that there is significant variation in CIED care quality."
Nearly 19,000 pacemakers and more than 4000 defibrillators were implanted in Australia alone last year. Pacemakers are often fitted to elderly people who suffer from bradycardia where their heart beats too slowly. They use electrical pulses to prompt the heart to beat at a normal rate. Cardioverter-defibrillators track a person's heart rate, and if an abnormal heart rhythm is detected, the device delivers an electric shock to restore the heart rhythm to normal.
"Serious complications can cause considerable patient harm and adds to avoidable health care costs. About 60 per cent of these complications occur after leaving the hospital so many doctors and hospitals may not be fully aware of the complications experienced by patients," says Dr Ranasinghe.
Associate Professor Anand Ganesan, a study co-investigator and a Cardiac Electrophysiologist at Flinders Medical Centre says: "What this study really shows is that we should be routinely reporting hospital complication rates to make these fully visible to clinicians, hospitals and the community at large. We should also invest in strategies proven to reduce these, such as optimising procedural technique, adopting better infection control measures, and managing blood thinning drugs peri-procedure."
Dr Ranasinghe says: "Encouraging hospitals to take part in quality improvement activities such as auditing complications and engaging in clinical quality registries also reduce complications over time."
Source: Eurekalert
Restrictive Transfusion Therapy Benefits Cardiac Surgery Patients
Lower thresholds for blood transfusions for cardiac surgery patients compared to traditional thresholds provide positive patient outcomes and safety at six months after surgery.
Advertisement
"Permanent pacemakers and implantable cardioverter-defibrillators are among the most common and costly devices implanted in hospitals."
"CIED complications are common with 8.2 per cent of patients implanted with new devices having a major device-related complication within 90 days of their operation. Complications experienced by patients vary between 2- and 3-fold among hospitals, which suggests that there is significant variation in CIED care quality."
Nearly 19,000 pacemakers and more than 4000 defibrillators were implanted in Australia alone last year. Pacemakers are often fitted to elderly people who suffer from bradycardia where their heart beats too slowly. They use electrical pulses to prompt the heart to beat at a normal rate. Cardioverter-defibrillators track a person's heart rate, and if an abnormal heart rhythm is detected, the device delivers an electric shock to restore the heart rhythm to normal.
"Serious complications can cause considerable patient harm and adds to avoidable health care costs. About 60 per cent of these complications occur after leaving the hospital so many doctors and hospitals may not be fully aware of the complications experienced by patients," says Dr Ranasinghe.
Associate Professor Anand Ganesan, a study co-investigator and a Cardiac Electrophysiologist at Flinders Medical Centre says: "What this study really shows is that we should be routinely reporting hospital complication rates to make these fully visible to clinicians, hospitals and the community at large. We should also invest in strategies proven to reduce these, such as optimising procedural technique, adopting better infection control measures, and managing blood thinning drugs peri-procedure."
Dr Ranasinghe says: "Encouraging hospitals to take part in quality improvement activities such as auditing complications and engaging in clinical quality registries also reduce complications over time."
Source: Eurekalert
Short-Term Statin Treatment Poses Risk of Kidney Damage Among Cardiac Surgery Patients
Atrial fibrillation is an increasingly common heart rhythm disorder and it increases the risk of a stroke by around four to five times.
Advertisement
New Method to Assess Options for Heart-disease Surgery DevelopedA new method to assess which patients with heart disease would benefit more from surgery which would benefit more from angioplasty has been developed by researchers. | Advertisement
|
Advertisement
Recommended Reading
Latest Heart Disease News
The first community-based study, published in the journal Lancet, says that delays in seeking care account for nearly 55% of the reported cardiac and stroke deaths in India.
The study emphasizes the existing proof on the heart disease risks of tobacco smoking and the urgent need to stop smoking among cancer survivors.
New study findings provide novel pathophysiological insights involving blood vessel integrity and tissue-mediated coagulation in a type of heart attack in young women.
Recent study identifies five heart failure subtypes with the potential for individual patient risk prediction.
In middle-age patients, CT scan identifies people who may benefit from drugs to decrease heart disease risk, stated study.